# Public Data Strategy

## Executive Summary

Cytognosis Foundation is committed to advancing global health through open science and responsible data sharing. Our public data strategy balances the imperative to accelerate medical research with the highest standards of privacy protection, regulatory compliance, and ethical data stewardship.

## Vision & Objectives

### Vision
To create the world's most comprehensive, diverse, and ethically managed public health datasets that accelerate AI-driven breakthroughs in preventive healthcare while ensuring privacy and promoting global health equity.

### Strategic Objectives
1. **Accelerate Research**: Enable breakthrough discoveries through high-quality public datasets
2. **Promote Equity**: Ensure diverse, representative datasets that address global health disparities
3. **Maintain Privacy**: Implement cutting-edge privacy-preserving technologies
4. **Foster Collaboration**: Build a global research ecosystem around shared data resources
5. **Ensure Sustainability**: Create long-term, sustainable data sharing models

## Public Dataset Portfolio

### Planned Public Datasets (2025-2030)

#### 1. Cytognosis Multimodal Prevention Dataset (CMPD)
**Target Release**: Q4 2025  
**Description**: De-identified multimodal health data for early disease detection research  
**Data Types**:
- Genomic variants (non-identifying)
- Proteomic biomarkers
- Medical imaging (anonymized)
- Clinical lab results
- Lifestyle and environmental factors

**Size**: 10,000+ participants  
**Use Cases**: Early detection algorithm development, biomarker discovery  
**Access**: Open access with data use agreement

#### 2. Global Health Disparities Dataset (GHDD)
**Target Release**: Q2 2026  
**Description**: Comprehensive dataset addressing health disparities across populations  
**Data Types**:
- Social determinants of health
- Healthcare access metrics
- Population health outcomes
- Geographic and demographic factors

**Size**: 100,000+ participants across 50+ countries  
**Use Cases**: Health equity research, policy development  
**Access**: Open access with attribution requirement

#### 3. AI-Ready Preventive Care Dataset (ARPCD)
**Target Release**: Q4 2026  
**Description**: Longitudinal dataset optimized for AI/ML model development  
**Data Types**:
- Time-series health measurements
- Intervention outcomes
- Predictive model features
- Validated ground truth labels

**Size**: 50,000+ participants with 5+ years follow-up  
**Use Cases**: Predictive model training, intervention effectiveness  
**Access**: Controlled access with research proposal review

#### 4. Federated Learning Benchmark Dataset (FLBD)
**Target Release**: Q1 2027  
**Description**: Standardized datasets for federated learning research in healthcare  
**Data Types**:
- Distributed synthetic datasets
- Privacy-preserving model benchmarks
- Cross-institutional validation sets

**Size**: Simulated data from 100+ institutions  
**Use Cases**: Federated learning algorithm development  
**Access**: Open access with technical requirements

#### 5. Cytognosis Synthetic Health Dataset (CSHD)
**Target Release**: Q3 2027  
**Description**: High-fidelity synthetic health data for unrestricted research use  
**Data Types**:
- Synthetic patient records
- Generated biomarker profiles
- Simulated clinical trials
- Privacy-guaranteed datasets

**Size**: 1,000,000+ synthetic patients  
**Use Cases**: Algorithm development, education, commercial research  
**Access**: Completely open with no restrictions

## Privacy-Preserving Technologies

### De-identification Framework
- **Safe Harbor Method**: Remove 18 HIPAA identifiers
- **Expert Determination**: Statistical disclosure control
- **K-anonymity**: Minimum group size requirements (k≥5)
- **L-diversity**: Sensitive attribute diversity
- **T-closeness**: Distribution similarity constraints

### Advanced Privacy Techniques
- **Differential Privacy**: Formal privacy guarantees with ε-δ privacy
- **Homomorphic Encryption**: Computation on encrypted data
- **Secure Multi-party Computation**: Collaborative analysis without data sharing
- **Federated Learning**: Model training without centralized data
- **Synthetic Data Generation**: GANs and VAEs for realistic synthetic datasets

### Privacy Risk Assessment
- **Re-identification Risk**: Quantitative assessment using prosecutor/journalist models
- **Membership Inference**: Protection against model-based attacks
- **Attribute Inference**: Prevention of sensitive attribute disclosure
- **Linkage Attacks**: Protection against external dataset linking
- **Temporal Correlation**: Mitigation of longitudinal re-identification risks

## Data Governance Framework

### Data Release Process
1. **Research Proposal**: Scientific merit and ethical review
2. **Privacy Assessment**: Comprehensive privacy risk analysis
3. **Legal Review**: Compliance with all applicable regulations
4. **Ethics Approval**: IRB and ethics committee approval
5. **Technical Validation**: Data quality and utility verification
6. **Community Review**: Stakeholder and community input
7. **Release Approval**: Final approval by Data Governance Committee

### Access Control Models

#### Open Access
- **No registration** required
- **Attribution** requirement only
- **Commercial use** permitted
- **Redistribution** allowed with attribution

#### Controlled Access
- **Research proposal** required
- **Institutional affiliation** verification
- **Data use agreement** mandatory
- **Annual reporting** on research outcomes

#### Federated Access
- **On-site analysis** only
- **No data download** permitted
- **Approved algorithms** only
- **Results review** before release

### Quality Assurance
- **Data Validation**: Automated and manual quality checks
- **Metadata Standards**: FAIR (Findable, Accessible, Interoperable, Reusable) compliance
- **Version Control**: Comprehensive dataset versioning and change tracking
- **Documentation**: Detailed data dictionaries and methodology descriptions
- **User Support**: Technical support and community forums

## Global Collaboration Framework

### International Partnerships

#### Academic Institutions
- **Harvard T.H. Chan School of Public Health**: Population health datasets
- **Oxford Big Data Institute**: Genomics and AI research collaboration
- **University of Toronto Vector Institute**: Federated learning research
- **Stanford HAI**: AI ethics and fairness in healthcare datasets
- **MIT CSAIL**: Privacy-preserving computation research

#### Healthcare Systems
- **Partners HealthCare**: Clinical data integration
- **Kaiser Permanente**: Longitudinal health records
- **NHS Digital**: Population-scale health data
- **All of Us Research Program**: Genomic diversity initiatives
- **UK Biobank**: Large-scale biomedical database collaboration

#### International Organizations
- **World Health Organization**: Global health data standards
- **Gates Foundation**: Global health equity initiatives
- **Wellcome Trust**: Open science and data sharing
- **Chan Zuckerberg Initiative**: Biomedical research acceleration
- **European Medicines Agency**: Regulatory data sharing

### Data Sharing Agreements
- **Bilateral Agreements**: Institution-to-institution data sharing
- **Multilateral Consortiums**: Multi-party research collaborations
- **International Compacts**: Cross-border data sharing frameworks
- **Public-Private Partnerships**: Industry collaboration agreements
- **Government Partnerships**: National health data initiatives

## Technical Infrastructure

### Data Platform Architecture
```
Public Data Platform
├── Data Ingestion Layer
│   ├── Privacy Processing Pipeline
│   ├── Quality Validation Engine
│   └── Metadata Generation System
├── Storage Layer
│   ├── Raw Data Vault (Encrypted)
│   ├── Processed Data Lake
│   └── Public Dataset Repository
├── Access Layer
│   ├── Open Access Portal
│   ├── Controlled Access System
│   └── Federated Analysis Platform
└── Analytics Layer
    ├── Privacy Risk Assessment
    ├── Usage Analytics
    └── Impact Measurement
```

### Cloud Infrastructure

- **PHI-bearing datasets** — `cytognosis-phi-prod` GCP project, with Customer-Managed Encryption Keys and a VPC Service Controls perimeter (see [`TECHNICAL_DATA_INFRASTRUCTURE.md`](TECHNICAL_DATA_INFRASTRUCTURE.md)).
- **De-identified public derivatives** — `cytognosis-data` project, public-readable buckets only after DLP API verification of zero PHI.
- **Static public assets** — `cytognosis-infrastructure` project, no PHI ever.
- **Backup** — Multi-region GCS replication for critical datasets; cross-cloud only for synthetic / FAIRified derivatives.
- **CDN** — Cloud CDN fronting public dataset distribution endpoints.
- **Compliance posture** — HIPAA (BAA with Google Cloud), ISO 27001 / 27799, SOC 2 (target).

### Data Formats and Standards
- **FHIR R4**: Healthcare data interoperability
- **HL7**: Clinical data exchange standards
- **OMOP CDM**: Observational health data standardization
- **GA4GH**: Genomics data sharing standards
- **DICOM**: Medical imaging data format

## Regulatory Compliance

### United States
- **HIPAA**: De-identification and privacy protections
- **FDA**: Medical device data requirements
- **NIH**: Data sharing policy compliance
- **21 CFR Part 11**: Electronic records and signatures
- **State Privacy Laws**: California CCPA, other state requirements

### European Union
- **GDPR**: Data protection and privacy rights
- **Medical Device Regulation (MDR)**: Clinical data requirements
- **Clinical Trials Regulation**: Research data sharing
- **AI Act**: Artificial intelligence governance
- **Data Governance Act**: Data sharing frameworks

### International
- **ISO 27001**: Information security management
- **ISO 13485**: Medical device quality management
- **ICH GCP**: Good Clinical Practice guidelines
- **Declaration of Helsinki**: Ethical principles for medical research
- **FAIR Principles**: Findable, Accessible, Interoperable, Reusable data

## Impact Measurement

### Research Impact Metrics
- **Dataset Downloads**: Number and frequency of dataset access
- **Research Publications**: Papers citing Cytognosis datasets
- **Citation Impact**: H-index and citation counts for dataset-derived research
- **Collaboration Networks**: Research partnerships enabled by data sharing
- **Innovation Metrics**: Patents and technologies developed using datasets

### Health Impact Metrics
- **Clinical Trials**: Number of trials using Cytognosis-derived insights
- **Regulatory Approvals**: Medical devices/drugs developed with our data
- **Health Outcomes**: Population health improvements attributable to research
- **Global Reach**: Countries and populations benefiting from research
- **Equity Measures**: Reduction in health disparities through research

### Community Impact Metrics
- **Researcher Engagement**: Active users and community participation
- **Educational Use**: Datasets used in academic curricula
- **Capacity Building**: Training programs and skill development
- **Open Science Adoption**: Influence on other organizations' data sharing
- **Policy Impact**: Influence on healthcare policy and regulation

## Sustainability Model

### Funding Strategy
- **Foundation Grants**: Philanthropic support for public good datasets
- **Government Funding**: NIH, NSF, and international research grants
- **Industry Partnerships**: Collaborative funding with ethical guidelines
- **User Fees**: Sustainable fees for premium services and support
- **Licensing Revenue**: Commercial licensing of synthetic datasets

### Long-term Sustainability
- **Endowment Fund**: Permanent funding for core dataset maintenance
- **Community Governance**: Stakeholder involvement in strategic decisions
- **Technology Evolution**: Continuous platform modernization and improvement
- **Global Expansion**: International funding and partnership development
- **Impact Demonstration**: Continuous measurement and communication of value

## Risk Management

### Privacy Risks
- **Re-identification**: Continuous monitoring and risk assessment
- **Data Breaches**: Comprehensive security and incident response
- **Regulatory Changes**: Proactive compliance monitoring and adaptation
- **Misuse Prevention**: Clear usage guidelines and monitoring systems
- **International Transfer**: Compliance with cross-border data regulations

### Operational Risks
- **Technical Failures**: Redundant systems and disaster recovery
- **Funding Shortfalls**: Diversified funding strategy and reserves
- **Partnership Disputes**: Clear agreements and dispute resolution
- **Quality Issues**: Rigorous quality assurance and validation processes
- **Reputation Management**: Transparent communication and ethical practices

## Future Roadmap

### 2025: Foundation Year
- Launch first public dataset (CMPD)
- Establish data governance framework
- Build initial research partnerships
- Implement core privacy technologies

### 2026: Expansion Year
- Release health disparities dataset (GHDD)
- Launch controlled access platform
- Establish international partnerships
- Begin federated learning initiatives

### 2027: Innovation Year
- Deploy advanced privacy-preserving technologies
- Launch synthetic data generation platform
- Establish global research consortium
- Begin commercial partnership program

### 2028-2030: Scale and Impact
- Achieve 1M+ researchers using datasets
- Demonstrate measurable health impact
- Establish sustainable funding model
- Influence global data sharing standards

---

**Document Owner**: Chief Data Officer, Cytognosis Foundation
**Contributors**: Research Team, Privacy Officers, Legal Counsel
**Companion to**: [`master-data-strategy.md`](master-data-strategy.md), [`dataset-catalog.md`](dataset-catalog.md)
**Last Updated**: May 2026
**Next Review**: November 2026
**Classification**: Public Document
